Literature DB >> 23928167

Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?

Y Hirsch-Moverman1, P W Colson, J Bethel, J Franks, W M El-Sadr.   

Abstract

OBJECTIVE: To assess the effectiveness of a peer-based intervention on adherence to and completion of latent tuberculous infection (LTBI) treatment.
METHODS: Patients prescribed self-administered LTBI treatment were enrolled in a randomized controlled trial of an experimental, peer-based adherence support intervention. Primary outcomes were treatment adherence and completion. Adherence was assessed through self-report, electronic monitoring devices and clinic visits.
RESULTS: Of 250 participants, 70% were male; 71% were Black and 20% Latino; the mean age was 40 years; 67% were foreign-born and 39% were married. No significant baseline differences were noted between the intervention groups. Treatment completion was 61% in the intervention group compared to 57% in the controls (P = 0.482). The corresponding completion rate for other clinic patients was 44%. Foreign birth, marriage and history of mental illness were associated with non-completion of treatment after controlling for the intervention group; increased completion rates were found among foreign-born married persons and older participants. A substantial difference in adherence rates was observed between the intervention groups. Adherence among non-completers decreased early, while adherence among completers remained constant.
CONCLUSIONS: The peer-based intervention was not significantly associated with LTBI treatment completion, but was associated with greater adherence. Findings suggest the importance of interventions to support adherence that target early non-adherence with LTBI treatment, particularly in the first 2 months, when there is a substantial risk of default.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928167      PMCID: PMC4477799          DOI: 10.5588/ijtld.12.0823

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  23 in total

1.  A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.

Authors:  Steven L Batki; Valerie A Gruber; Julia Moon Bradley; Mark Bradley; Kevin Delucchi
Journal:  Drug Alcohol Depend       Date:  2002-05-01       Impact factor: 4.492

2.  Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

Authors:  A Trajman; R Long; D Zylberberg; M J Dion; B Al-Otaibi; D Menzies
Journal:  Int J Tuberc Lung Dis       Date:  2010-05       Impact factor: 2.373

3.  Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail.

Authors:  Mary Castle White; Jacqueline P Tulsky; Joe Goldenson; Carmen J Portillo; Masae Kawamura; Enrique Menendez
Journal:  Arch Intern Med       Date:  2002-05-13

4.  A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Authors:  R E Chaisson; G L Barnes; J Hackman; L Watkinson; L Kimbrough ; S Metha; S Cavalcante; R D Moore
Journal:  Am J Med       Date:  2001-06-01       Impact factor: 4.965

5.  Lasagna plots: a saucy alternative to spaghetti plots.

Authors:  Bruce J Swihart; Brian Caffo; Bryan D James; Matthew Strand; Brian S Schwartz; Naresh M Punjabi
Journal:  Epidemiology       Date:  2010-09       Impact factor: 4.822

6.  Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

Authors:  Diane E Bennett; Jeanne M Courval; Ida Onorato; Tracy Agerton; Judy D Gibson; Lauren Lambert; Geraldine M McQuillan; Brenda Lewis; Thomas R Navin; Kenneth G Castro
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

7.  Can the poor adhere? Incentives for adherence to TB prevention in homeless adults.

Authors:  J P Tulsky; J A Hahn; H L Long; D B Chambers; M J Robertson; M A Chesney; A R Moss
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

8.  Cultural case management of latent tuberculosis infection.

Authors:  S V Goldberg; J Wallace; J C Jackson; C P Chaulk; C M Nolan
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

Review 9.  Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada.

Authors:  Y Hirsch-Moverman; A Daftary; J Franks; P W Colson
Journal:  Int J Tuberc Lung Dis       Date:  2008-11       Impact factor: 2.373

10.  Latent TB infection treatment acceptance and completion in the United States and Canada.

Authors:  C Robert Horsburgh; Stefan Goldberg; James Bethel; Shande Chen; Paul W Colson; Yael Hirsch-Moverman; Stephen Hughes; Robin Shrestha-Kuwahara; Timothy R Sterling; Kirsten Wall; Paul Weinfurter
Journal:  Chest       Date:  2009-09-30       Impact factor: 9.410

View more
  5 in total

1.  Antiretroviral therapy in Zambia: do partners on ART enhance adherence?

Authors:  Deborah Jones; Ryan Cook; Andrew Spence; Stephen M Weiss; Ndashi Chitalu
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-10-07

2.  Expanding Latent Tuberculosis Infection Testing and Treatment in Massachusetts Primary Care Clinics via the ECHO Model.

Authors:  Daria Szkwarko; Michael E Urbanowski; Rebecca Thal; Patricia Iyer; Susan Foley; Liisa M Randall; John Bernardo; Judith A Savageau; Jennifer Cochran
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

3.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

Review 4.  Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Authors:  Haileyesus Getahun; Alberto Matteelli; Ibrahim Abubakar; Mohamed Abdel Aziz; Annabel Baddeley; Draurio Barreira; Saskia Den Boon; Susana Marta Borroto Gutierrez; Judith Bruchfeld; Erlina Burhan; Solange Cavalcante; Rolando Cedillos; Richard Chaisson; Cynthia Bin-Eng Chee; Lucy Chesire; Elizabeth Corbett; Masoud Dara; Justin Denholm; Gerard de Vries; Dennis Falzon; Nathan Ford; Margaret Gale-Rowe; Chris Gilpin; Enrico Girardi; Un-Yeong Go; Darshini Govindasamy; Alison D Grant; Malgorzata Grzemska; Ross Harris; C Robert Horsburgh; Asker Ismayilov; Ernesto Jaramillo; Sandra Kik; Katharina Kranzer; Christian Lienhardt; Philip LoBue; Knut Lönnroth; Guy Marks; Dick Menzies; Giovanni Battista Migliori; Davide Mosca; Ya Diul Mukadi; Alwyn Mwinga; Lisa Nelson; Nobuyuki Nishikiori; Anouk Oordt-Speets; Molebogeng Xheedha Rangaka; Andreas Reis; Lisa Rotz; Andreas Sandgren; Monica Sañé Schepisi; Holger J Schünemann; Surender Kumar Sharma; Giovanni Sotgiu; Helen R Stagg; Timothy R Sterling; Tamara Tayeb; Mukund Uplekar; Marieke J van der Werf; Wim Vandevelde; Femke van Kessel; Anna van't Hoog; Jay K Varma; Natalia Vezhnina; Constantia Voniatis; Marije Vonk Noordegraaf-Schouten; Diana Weil; Karin Weyer; Robert John Wilkinson; Takashi Yoshiyama; Jean Pierre Zellweger; Mario Raviglione
Journal:  Eur Respir J       Date:  2015-09-24       Impact factor: 16.671

Review 5.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.